Psychogenic dwarfism overview: Difference between revisions

Jump to navigation Jump to search
Prashanthsaddala (talk | contribs)
Created page with "__NOTOC__ {{Psychogenic dwarfism}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{R..."
 
Prashanthsaddala (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Psychogenic dwarfism}}
{{Psychogenic dwarfism}}
Please help WikiDoc by adding content here.  It's easy!  Click [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{CMG}}
==Overview==
'''Psychogenic [[dwarfism]]''', Psychosocial short stature or Stress dwarfism is a growth disorder that is observed between the ages of 2 and 15, caused by extreme emotional deprivation or [[stress (medicine)|stress]].
 
Psychogenic dwarfism is [[short stature]] that results from an environment with constant and extreme [[stress]]. Usual signs and symptoms include short stature, weight that is inappropriate for the height, and immature [[bone age]], an adult height around 4 feet (about 122 centimeters). For diagnosis, evaluation of child's growth and develpment environment, appearance examination and measurements of height and weight, hormone tests and imaging technology may be helpful. Treatments for most dwarfism-related conditions don't increase stature but may lessen complications. Children of psychogenic dwarfism may receive hormone therapy for a long time. Prognosis of psyvhogenic dwarfism varies from condition to condition, from person to person. Family support, social networks, advocacy groups and adaptive products enable most patients to address challenges in educational, work and social settings.
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 19:21, 19 September 2012

Psychogenic dwarfism Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Psychogenic dwarfism from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Psychogenic dwarfism overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Psychogenic dwarfism overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Psychogenic dwarfism overview

CDC on Psychogenic dwarfism overview

Psychogenic dwarfism overview in the news

Blogs on Psychogenic dwarfism overview

Directions to Hospitals Treating Psychogenic dwarfism

Risk calculators and risk factors for Psychogenic dwarfism overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Psychogenic dwarfism, Psychosocial short stature or Stress dwarfism is a growth disorder that is observed between the ages of 2 and 15, caused by extreme emotional deprivation or stress.

Psychogenic dwarfism is short stature that results from an environment with constant and extreme stress. Usual signs and symptoms include short stature, weight that is inappropriate for the height, and immature bone age, an adult height around 4 feet (about 122 centimeters). For diagnosis, evaluation of child's growth and develpment environment, appearance examination and measurements of height and weight, hormone tests and imaging technology may be helpful. Treatments for most dwarfism-related conditions don't increase stature but may lessen complications. Children of psychogenic dwarfism may receive hormone therapy for a long time. Prognosis of psyvhogenic dwarfism varies from condition to condition, from person to person. Family support, social networks, advocacy groups and adaptive products enable most patients to address challenges in educational, work and social settings.

References


Template:WikiDoc Sources